Informex USA 2013


The Informex USA, to be held Feb. 19-22 at the Anaheim Convention Center promises to offer its expected 4,000+ attendees a direct view of what is happening in the varied chemical marketplaces. With this focus and the presence of 500+ international exhibitors, there is exceptional vertical insight in many markets, including: textiles, electronics, food and beverage, fuel and lubricants, soaps and detergents, water treatment, flavors and fragrances, adhesives and resins, paint and coatings, cosmetics and personal care, biopharmaceuticals, plastics and polymers, organic chemicals, agrochemicals, pharmaceuticals and more.
Informex USA is the only event of its kind offering exhibitors & attendees a direct view of what is happening globally across the fine, specialty & custom chemical marketplace. The event brings together an international mix of motivated buyers and sellers of high value chemistry for 4 days of sourcing, education & networking.
Throughout the four days of the event, InformexUSA is able to offer an opportunity to make business connections with leaders in established and emerging pharma markets, the cosmetics/personal care industry, the biopharma sector, agrochemical manufacturers, plastics/polymers professionals, branded, generic, and mid-sized specialty pharma companies.
The exhibition format is complemented by a comprehensive world-class conference program. The extensive networking events & strategic partnerships with key industry associations deliver an unprecedented return on investment making InformexUSA the industry leader for over 28 years.
Meist gelesen

Boehringer Ingelheim ebnet Weg für wichtige Markteinführungen
Boehringer Ingelheim verzeichnete im ersten Halbjahr 2025 ein positives Wachstum mit einem Anstieg des Konzernumsatzes um 6,3% auf 14,0 Mrd. EUR.

Boehringer Ingelheim benennt neuen Vorsitzenden der Unternehmensleitung
Der Gesellschafterausschuss von Boehringer Ingelheim hat Shashank Deshpande, Mitglied der Unternehmensleitung und Leiter des Geschäftsbereichs Humanpharma, ab dem 1. Juli 2025 zum Vorsitzenden der Unternehmensleitung ernannt.

Oxea ernennt Michael McHenry zum neuen Chief Executive Officer
Das Monheimer Chemieunternehmen Oxea hat Michael McHenry mit Wirkung zum 15. August 2025 zum neuen Chief Executive Officer (CEO) ernannt.

Sudarshan schließt Heubach-Übernahme ab
Sudarshan hat über seine hundertprozentige Tochtergesellschaft Sudarshan Europe die strategische Übernahme der Heubach-Gruppe abgeschlossen.
